Company: CORT
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001628280-25-037005
Chunk: 175

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-07-31
Form: 10-Q
Item: Part I, Item 3
Chunk 175
---
 in satisfaction of related exercise cost and tax obligations. In May 2025, we issued 108,494 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 35,265 shares were surrendered to us. In June 2025, we issued 266,414 shares of common stock as part of a net-share settlement of a cashless option exercise, of which 129,315 shares were surrendered to us.

In April 2025, we issued 28,782 shares of common stock as part of restricted stock vesting, of which 10,681 shares were surrendered to us in satisfaction of related tax obligations. In May 2025, we issued 81,616 shares of common stock as part of restricted stock vesting, of which 29,906 shares were surrendered to us. In June 2025, we issued 68,245 shares of common stock as part of restricted stock vesting, of which 23,579 shares were surrendered to us.

(2) We paid $12.4 million to satisfy the tax withholding obligations associated with the net-share settlement of these cashless option exercises and vesting of restricted stock.